Litcius/Paper detail

Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer

Tomer Meirson, Daniel A. Goldstein, Bishal Gyawali, Ian F. Tannock

2023The Lancet Oncology25 citationsDOI

Topics & Concepts

MedicineBreast cancerAdjuvantOncologyInternal medicineAdjuvant therapyClinical trialPopulationRandomized controlled trialCancerDiseaseFamily medicineEnvironmental healthAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer-related Molecular Pathways
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer | Litcius